Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Sunday, June 8, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
Novartis Pluvictoâ„¢ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
admin
-
June 4, 2025
Latest Pharma-News
FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People
admin
-
June 4, 2025
Latest Pharma-News
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
admin
-
April 11, 2025
Latest Pharma-News
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
admin
-
April 9, 2025
Latest Pharma-News
Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy
admin
-
April 9, 2025
Latest Pharma-News
Nestlé Health Sciences and valbiotis agree to create and market TOTUM-63, a plant-derived active substance with clinically proven metabolic health benefits
admin
-
February 9, 2020
0
Latest Pharma-News
USFDA Authorizes Marketing of the First Cardiac Ultrasound Software That Uses Artificial Intelligence to Guide User
admin
-
February 8, 2020
0
Latest Pharma-News
Sanofi brain-penetrant BTK (Bruton’s tyrosine kinase) inhibitor meets primary endpoint of Phase 2 trial in relapsing multiple sclerosis
admin
-
February 8, 2020
0
Latest Pharma-News
Aquestive Therapeutics Announces FDA Confirmed 505(b)(2) Pathway for AQST-108 (Sublingual Film Formulation Delivering Systemic Epinephrine) for Anaphylaxis Treatment
admin
-
February 7, 2020
0
Latest Pharma-News
FDA Moves Closer to the Standardized Testing for Asbestos in Talc
admin
-
February 7, 2020
0
Latest Pharma-News
VIVUS Receives U.S. FDA Approval for the Improved Formulation of PANCREAZE® with a 36-Month Shelf Life
admin
-
February 7, 2020
0
Latest Pharma-News
U.S.FDA approves Alector’s Fast Track Designation Granted to AL101 for the Treatment of Patients with Frontotemporal Dementia
admin
-
February 7, 2020
0
Latest Pharma-News
BioXcel Therapeutics Announces FDA Clearance of IND Application for BXCL501 (dexmedetomidine)for the Treatment of Opioid Withdrawal Symptoms
admin
-
February 7, 2020
0
Latest Pharma-News
MorphoSys Initiates Expanded Access Program for Tafasitamab (anti-CD19 antibody) in the U.S.
admin
-
February 6, 2020
0
Latest Pharma-News
CEPI and GSK announce new collaboration to strengthen the global effort to develop a vaccine for the coronavirus (2019-nCoV virus)
admin
-
February 6, 2020
0
Latest Pharma-News
GRADUATE PHARMACY APTITUDE TEST (GPAT): GPAT Result 2020
admin
-
February 5, 2020
0
Latest Pharma-News
Vituro Health Successfully Completes First three TULSA-PRO® treatments to ablate prostate tissue in the United States Following FDA 510(K) Clearance
admin
-
February 5, 2020
0
1
...
130
131
132
...
145
Page 131 of 145
- Advertisment -
Most Read
Novartis Pluvictoâ„¢ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
June 4, 2025
FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People
June 4, 2025
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
April 11, 2025
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
April 9, 2025